Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Diabetes Mellitus, Type 2 × dapagliflozin × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4 Prostatic Neoplasms 2 Solid Tumors 1 Pediatric Brain Tumor 1 Lung Neoplasms 1 Inflammation 1 Heart Failure 1 Diabetes Mellitus, Type 2 1 Diabetes Mellitus 1 Adenocarcinoma of Lung 1

Interventions

relacorilant 3 saxagliptin 1 mazdutide 1 dapagliflozin 1 Urine Specimen Collection 1 Sulfonylurea Compounds 1 Sodium-Glucose Transporter 2 Inhibitors 1 Nutrition Assessment 1 Dipeptidyl-Peptidase IV Inhibitors 1 Blood Specimen Collection 1 Biopsy 1 ASP3662 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07033585 2025-07-11

GD-T2D

Medicine Invention Design, Inc

Phase 2/3 Active not recruiting

Diabetes Mellitus, Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡